Archetype Therapeutics
The AI engine Fit Assessment
BetaArchetype effectively utilizes machine learning for drug discovery, pattern discovery in patient data, and has a proven track record in expanding therapeutics through drug repurposing.
Blurb
Archetype Therapeutics is an AI-native biotech firm specializing in computational drug discovery and repurposing.
HQ Location
Winchester (United States)
Founded
2022
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
- Drug Repurposing
Archetype Therapeutics is an AI-native biotechnology company that focuses on computational drug discovery and repurposing. Utilizing proprietary and patent-pending technology, the company bridges translational gaps in drug development. Archetype Therapeutics leverages generative chemogenomics to predict clinical trial and real-world outcomes, discovering new and repurposed drugs for various diseases, including metastatic conditions.